StonvexLoading…
StonvexStonvexStonvexCore line items from ROL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.76B | $3.39B | $3.07B | $2.70B |
Operating Income | $726.07M | $657.22M | $583.23M | $493.39M |
Net Income | $526.71M | $466.38M | $434.96M | $368.60M |
EPS (Diluted) | $1.09 | $0.96 | $0.89 | $0.75 |
Total Assets | $3.14B | $2.82B | $2.60B | $2.12B |
Total Liabilities | $1.77B | $1.49B | $1.44B | $854.83M |
Cash & Equivalents | $100.00M | $89.63M | $103.83M | $95.35M |
Free Cash Flow OCF − CapEx | $650.02M | $580.08M | $495.90M | $435.30M |
Shares Outstanding | 481.19M | 484.37M | 484.08M | 492.45M |